These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35764242)

  • 1. A Self-amplifying ROS-sensitive prodrug-based nanodecoy for circumventing immune resistance in chemotherapy-sensitized immunotherapy.
    Zhang J; Sun X; Xu M; Zhao X; Yang C; Li K; Zhao F; Hu H; Qiao M; Chen D; Zhao X
    Acta Biomater; 2022 Sep; 149():307-320. PubMed ID: 35764242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH-Responsive Micellar Nanoparticles for the Delivery of a Self-Amplifying ROS-Activatable Prodrug.
    Kannaujiya VK; Qiao Y; Sheikh RH; Xue J; Dargaville TR; Liang K; Wich PR
    Biomacromolecules; 2024 Mar; 25(3):1775-1789. PubMed ID: 38377594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic amplification of intracellular ROS boosts enzymatic prodrug activation for enhanced chemo-immunotherapy.
    Liu Y; Jiang M; Zhao Z; Wang N; Wang K; Yuan Y
    Acta Biomater; 2023 Aug; 166():567-580. PubMed ID: 37207741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient tumor synergistic chemoimmunotherapy by self-augmented ROS-responsive immunomodulatory polymeric nanodrug.
    Song J; Cheng M; Xie Y; Li K; Zang X
    J Nanobiotechnology; 2023 Mar; 21(1):93. PubMed ID: 36927803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactive oxygen species-activatable self-amplifying Watson-Crick base pairing-inspired supramolecular nanoprodrug for tumor-specific therapy.
    Xu X; Zeng Z; Ding X; Shan T; Liu Q; Chen M; Chen J; Xia M; He Y; Huang Z; Huang Y; Zhao C
    Biomaterials; 2021 Oct; 277():121128. PubMed ID: 34537502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prodrug hydrogel with tumor microenvironment and near-infrared light dual-responsive action for synergistic cancer immunotherapy.
    Ding M; Fan Y; Lv Y; Liu J; Yu N; Kong D; Sun H; Li J
    Acta Biomater; 2022 Sep; 149():334-346. PubMed ID: 35779775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tumor-specific ROS self-supply enhanced cascade-responsive prodrug activation nanosystem for amplified chemotherapy against multidrug-resistant tumors.
    Wang J; Zhang H; Lv J; Zheng Y; Li M; Yang G; Wei X; Li N; Huang H; Li T; Qin X; Li S; Wu C; Zhang W; Liu Y; Yang H
    Acta Biomater; 2023 Jul; 164():522-537. PubMed ID: 37072069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated macrophage membrane-camouflaged pH-responsive polymeric micelles for combined cancer chemotherapy-sensitized immunotherapy.
    Du T; Wang Y; Luan Z; Zhao C; Yang K
    Int J Pharm; 2022 Aug; 624():121911. PubMed ID: 35700870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A versatile strategy to create an active tumor-targeted chemo-photothermal therapy nanoplatform: A case of an IR-780 derivative co-assembled with camptothecin prodrug.
    He W; Jiang Y; Li Q; Zhang D; Li Z; Luan Y
    Acta Biomater; 2019 Jan; 84():356-366. PubMed ID: 30502480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Triple-Responsive Polymeric Prodrug Nanoplatform with Extracellular ROS Consumption and Intracellular H
    Li Y; Cao Y; Ma K; Ma R; Zhang M; Guo Y; Song H; Sun N; Zhang Z; Yang W
    Adv Healthc Mater; 2024 Jun; 13(16):e2303568. PubMed ID: 38319010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH/ROS dual-responsive supramolecular polypeptide prodrug nanomedicine based on host-guest recognition for cancer therapy.
    Ding Y; Wang C; Ma Y; Zhu L; Lu B; Wang Y; Wang J; Chen T; Dong CM; Yao Y
    Acta Biomater; 2022 Apr; 143():381-391. PubMed ID: 35272024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactive oxygen species-activated self-amplifying prodrug nanoagent for tumor-specific Cu-chelate chemotherapy and cascaded photodynamic therapy.
    Chen J; Tan X; Huang Y; Xu C; Zeng Z; Shan T; Guan Z; Xu X; Huang Z; Zhao C
    Biomaterials; 2022 May; 284():121513. PubMed ID: 35398586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A camptothecin prodrug induces mitochondria-mediated apoptosis in cancer cells with cascade activations.
    Luo X; Chi X; Lin Y; Yang Z; Lin H; Gao J
    Chem Commun (Camb); 2021 Oct; 57(84):11033-11036. PubMed ID: 34608474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mitochondria-targeting ROS-activated nanoprodrug for self-augmented antitumor oxidation therapy.
    Zeng Z; Luo Y; Xu X; Shan T; Chen M; Huang Z; Huang Y; Zhao C
    J Control Release; 2023 Jul; 359():415-427. PubMed ID: 37290720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ROS triggered cleavage of thioketal moiety to dissociate prodrug nanoparticles for chemotherapy.
    Pan Q; Deng X; Gao W; Chang J; Pu Y; He B
    Colloids Surf B Biointerfaces; 2020 Oct; 194():111223. PubMed ID: 32615519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System.
    Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P
    Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast Activation Protein-α Responsive Peptide Assembling Prodrug Nanoparticles for Remodeling the Immunosuppressive Microenvironment and Boosting Cancer Immunotherapy.
    Sun M; Yao S; Fan L; Fang Z; Miao W; Hu Z; Wang Z
    Small; 2022 Mar; 18(9):e2106296. PubMed ID: 34914185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper-coordinated nanoassemblies based on photosensitizer-chemo prodrugs and checkpoint inhibitors for enhanced apoptosis-cuproptosis and immunotherapy.
    Liang W; Han C; Zhang D; Liu C; Zhu M; Xu F; Fang C; Zhang S; Liu C; Li Y
    Acta Biomater; 2024 Feb; 175():341-352. PubMed ID: 38122883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prodrug-Based Versatile Nanomedicine with Simultaneous Physical and Physiological Tumor Penetration for Enhanced Cancer Chemo-Immunotherapy.
    Guo Z; Hu Y; Zhao M; Hao K; He P; Tian H; Chen X; Chen M
    Nano Lett; 2021 May; 21(9):3721-3730. PubMed ID: 33891423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docetaxel-loaded pH/ROS dual-responsive nanoparticles with self-supplied ROS for inhibiting metastasis and enhancing immunotherapy of breast cancer.
    Wang Y; Wang Q; Wang X; Yao P; Dai Q; Qi X; Yang M; Zhang X; Huang R; Yang J; Wang Q; Xia P; Zhang D; Sun F
    J Nanobiotechnology; 2023 Aug; 21(1):286. PubMed ID: 37608285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.